Bradford B. Walters
Direktor/Vorstandsmitglied bei Kucera Pharmaceutical Co.
Profil
Bradford B.
Walters is currently the Director at Kucera Pharmaceutical Co. since 2011.
He previously worked as a Director at Curry Pharmaceuticals Corp., Cantex Pharmaceuticals, Inc., Wake Forest University, and Academy Ventures LLC.
He also served as a Member at North Carolina Medical Society in 2000 and as an Associate Professor at The University of North Carolina at Charlotte.
Dr. Walters completed his undergraduate degree at Harvard University, obtained an MBA from The University of North Carolina at Chapel Hill in 2001, and holds a doctorate from University College London.
Aktive Positionen von Bradford B. Walters
Unternehmen | Position | Beginn |
---|---|---|
Kucera Pharmaceutical Co.
Kucera Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Kucera is developing a pipeline of drugs that have improved efficacy and potentially improved toxicity profiles by taking advantage of the unique biological and chemical properties of its proprietary small molecule platform. Kucera has small molecules which act alone as therapeutic agents. Kucera's unique proprietary molecules can also be chemically conjugated to other small molecule drugs creating a series of carrier prodrugs. Both the prodrugs and small molecules will be classified as new chemical entities (NCEs) and will benefit from a new or an extended patent on the existing small molecule. Kucera's headquarters is in the Piedmont Triad Research Park, Winston-Salem, N.C. Kucera Pharmaceutical Co. The company was founded on June 14, 2001 and is headquartered in Winston Salem, NC. | Direktor/Vorstandsmitglied | 02.08.2011 |
Ehemalige bekannte Positionen von Bradford B. Walters
Unternehmen | Position | Ende |
---|---|---|
North Carolina Medical Society
North Carolina Medical Society Miscellaneous Commercial ServicesCommercial Services The North Carolina Medical Society is a professional organization based in Raleigh, NC. The non-profit company's main focus is not specified in the provided metadata. The CEO of the company is Bob Seligson. | Corporate Officer/Principal | 01.01.2000 |
The University of North Carolina at Charlotte | Corporate Officer/Principal | - |
Curry Pharmaceuticals Corp.
Curry Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Curry Pharmaceuticals Corp. develops pharmaceutical products. It offers novel drugs for cancer, oncology, dermatology and other inflammatory diseases based on the natural product curcumin. The company was founded in 2003 by Dennis P. Schafer, Lowell A. Goldsmith, and Bharat Aggarwal and is headquartered in Durham, NC. | Direktor/Vorstandsmitglied | - |
Wake Forest University | Corporate Officer/Principal | - |
Academy Ventures LLC
Academy Ventures LLC Investment ManagersFinance Academy Funds is a family of venture capital funds located in Durham, North Carolina with an additional office in Greenville, South Carolina | Corporate Officer/Principal | - |
Ausbildung von Bradford B. Walters
Harvard University | Undergraduate Degree |
The University of North Carolina at Chapel Hill | Masters Business Admin |
University College London | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Curry Pharmaceuticals Corp.
Curry Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Curry Pharmaceuticals Corp. develops pharmaceutical products. It offers novel drugs for cancer, oncology, dermatology and other inflammatory diseases based on the natural product curcumin. The company was founded in 2003 by Dennis P. Schafer, Lowell A. Goldsmith, and Bharat Aggarwal and is headquartered in Durham, NC. | Health Technology |
Cantex Pharmaceuticals, Inc.
Cantex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cantex Pharmaceuticals, Inc. develops heparin to ameliorate cardiac ischemia-reperfusion injuries. It also develops medications to enhance the safety and effectiveness of existing cancer treatments. The firm provides Disulfiram + copper Chelate that includes non-overlapping cancer stem cell killing mechanisms of actions. The company was founded in 2013 by Thomas P. Kennedy, Neil William Flanzraich and Stephen G. Marcus and is headquartered in Weston, FL. | Health Technology |
Academy Ventures LLC
Academy Ventures LLC Investment ManagersFinance Academy Funds is a family of venture capital funds located in Durham, North Carolina with an additional office in Greenville, South Carolina | Finance |
North Carolina Medical Society
North Carolina Medical Society Miscellaneous Commercial ServicesCommercial Services The North Carolina Medical Society is a professional organization based in Raleigh, NC. The non-profit company's main focus is not specified in the provided metadata. The CEO of the company is Bob Seligson. | Commercial Services |
Kucera Pharmaceutical Co.
Kucera Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Kucera is developing a pipeline of drugs that have improved efficacy and potentially improved toxicity profiles by taking advantage of the unique biological and chemical properties of its proprietary small molecule platform. Kucera has small molecules which act alone as therapeutic agents. Kucera's unique proprietary molecules can also be chemically conjugated to other small molecule drugs creating a series of carrier prodrugs. Both the prodrugs and small molecules will be classified as new chemical entities (NCEs) and will benefit from a new or an extended patent on the existing small molecule. Kucera's headquarters is in the Piedmont Triad Research Park, Winston-Salem, N.C. Kucera Pharmaceutical Co. The company was founded on June 14, 2001 and is headquartered in Winston Salem, NC. | Health Technology |